Acadian Asset Management
RVLP

Acadian Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Acadian Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-154,683
Closed -$1.04M – 2414
2020
Q2 		$1.04M Sell
154,683
-174,153
-53% -$852K ﹤0.01% 950
2020
Q1 		$1.05M Buy
328,836
+154,541
+89% +$823K 0.01% 780
2019
Q4 		$1.22M Buy
174,295
+115,378
+196% +$616K 0.01% 828
2019
Q3 		$226K Buy
58,917
+5,071
+9% +$17.2K ﹤0.01% 1296
2019
Q2 		$206K Buy
53,846
+39,584
+278% +$132K ﹤0.01% 1222
2019
Q1 		$52K Buy
+14,262
New +$105K ﹤0.01% 1664

Other funds holding RVLP

DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management's RVLP Position: Q3 2020 in Review

Acadian Asset Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2020, closing a stake of 154,683 shares — an estimated $1.04M sold.

Acadian Asset Management first reported a position in RVLP in Q1 2019 and held it in 6 quarters. The position peaked at $1.22M in Q4 2019. 62 funds tracked by Wall St. Rank hold RVLP as of Q3 2020.

  • Acadian Asset Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Acadian Asset Management sold 154,683 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2020, an estimated $1.04M.
  • Acadian Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 6 quarters.
  • Acadian Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.22M in Q4 2019.
  • 62 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2020.

Based on Acadian Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.